Cargando…

Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up

BACKGROUND: Opioids are still widely prescribed to long-term pain patients although they are no longer recommended for long-term treatments due to poor evidence for long-term efficacy, risks of serious side effects, and the possibility of inducing opioid hyperalgesia. In a Cochrane study from 2017,...

Descripción completa

Detalles Bibliográficos
Autores principales: Henrik, Grelz, Patrik, Midlöv, Anders, Håkansson, Ulf, Jakobsson, Marcelo, Rivano Fischer, Åsa, Ringqvist
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318331/
https://www.ncbi.nlm.nih.gov/pubmed/34321058
http://dx.doi.org/10.1186/s13063-021-05449-5
_version_ 1783730224842670080
author Henrik, Grelz
Patrik, Midlöv
Anders, Håkansson
Ulf, Jakobsson
Marcelo, Rivano Fischer
Åsa, Ringqvist
author_facet Henrik, Grelz
Patrik, Midlöv
Anders, Håkansson
Ulf, Jakobsson
Marcelo, Rivano Fischer
Åsa, Ringqvist
author_sort Henrik, Grelz
collection PubMed
description BACKGROUND: Opioids are still widely prescribed to long-term pain patients although they are no longer recommended for long-term treatments due to poor evidence for long-term efficacy, risks of serious side effects, and the possibility of inducing opioid hyperalgesia. In a Cochrane study from 2017, the authors identified an urgent need for more randomized controlled trials investigating the efficiency and effects of opioid tapering. The study aimed to assess (1) the efficiency of a structured intervention in causing stable reductions of opioid consumption in a population with long-term non-malignant pain and (2) effects on pain, pain cognitions, physical and mental health, quality of life, and functioning in response to opioid tapering. METHODS: The study is a randomized controlled trial. The sample size was set to a total of 140 individuals after estimation of power and dropout. Participants will be recruited from a population with long-term non-malignant pain who will be randomly allocated to (1) the start of tapering immediately or (2) the control group who return to usual care and will commence tapering of opioids 4 months later. A 12-month follow-up is included. When all follow-ups are closed, data from the Swedish drug register of the National Board of Health and Welfare will be collected and individual mean daily opioid dose in morphine equivalents will be calculated at three time points: baseline, 4 months, and 12 months after the start of the intervention. At the same time points, participants fill out the following questionnaires: Numeric Pain Rating Scale (NPRS), Tampa Scale of Kinesiophobia (TSK), Pain Catastrophizing Scale (PCS), Chronic Pain Acceptance Questionnaire (CPAQ-8), Hospital Anxiety and Depression Scale (HADS), and RAND-36. At baseline and follow-up, a clinical assessment of opioid use disorder is performed. DISCUSSION: A better understanding of the efficiency and effects of opioid tapering could possibly facilitate attempts to taper opioid treatments, which might prove beneficial for both the individual and society. TRIAL REGISTRATION: ClinicalTrials.gov NCT03485430. Retrospectively registered on 26 March 2018, first release date. “Tapering of Long-term Opioid Therapy in Chronic Pain Population. RCT with 12 Months Follow up (TOPIO).” First patient in trial 22 March 2018.
format Online
Article
Text
id pubmed-8318331
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83183312021-07-29 Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up Henrik, Grelz Patrik, Midlöv Anders, Håkansson Ulf, Jakobsson Marcelo, Rivano Fischer Åsa, Ringqvist Trials Study Protocol BACKGROUND: Opioids are still widely prescribed to long-term pain patients although they are no longer recommended for long-term treatments due to poor evidence for long-term efficacy, risks of serious side effects, and the possibility of inducing opioid hyperalgesia. In a Cochrane study from 2017, the authors identified an urgent need for more randomized controlled trials investigating the efficiency and effects of opioid tapering. The study aimed to assess (1) the efficiency of a structured intervention in causing stable reductions of opioid consumption in a population with long-term non-malignant pain and (2) effects on pain, pain cognitions, physical and mental health, quality of life, and functioning in response to opioid tapering. METHODS: The study is a randomized controlled trial. The sample size was set to a total of 140 individuals after estimation of power and dropout. Participants will be recruited from a population with long-term non-malignant pain who will be randomly allocated to (1) the start of tapering immediately or (2) the control group who return to usual care and will commence tapering of opioids 4 months later. A 12-month follow-up is included. When all follow-ups are closed, data from the Swedish drug register of the National Board of Health and Welfare will be collected and individual mean daily opioid dose in morphine equivalents will be calculated at three time points: baseline, 4 months, and 12 months after the start of the intervention. At the same time points, participants fill out the following questionnaires: Numeric Pain Rating Scale (NPRS), Tampa Scale of Kinesiophobia (TSK), Pain Catastrophizing Scale (PCS), Chronic Pain Acceptance Questionnaire (CPAQ-8), Hospital Anxiety and Depression Scale (HADS), and RAND-36. At baseline and follow-up, a clinical assessment of opioid use disorder is performed. DISCUSSION: A better understanding of the efficiency and effects of opioid tapering could possibly facilitate attempts to taper opioid treatments, which might prove beneficial for both the individual and society. TRIAL REGISTRATION: ClinicalTrials.gov NCT03485430. Retrospectively registered on 26 March 2018, first release date. “Tapering of Long-term Opioid Therapy in Chronic Pain Population. RCT with 12 Months Follow up (TOPIO).” First patient in trial 22 March 2018. BioMed Central 2021-07-28 /pmc/articles/PMC8318331/ /pubmed/34321058 http://dx.doi.org/10.1186/s13063-021-05449-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Henrik, Grelz
Patrik, Midlöv
Anders, Håkansson
Ulf, Jakobsson
Marcelo, Rivano Fischer
Åsa, Ringqvist
Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
title Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
title_full Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
title_fullStr Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
title_full_unstemmed Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
title_short Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
title_sort tapering of prescribed opioids in patients with long-term non-malignant pain (topio)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318331/
https://www.ncbi.nlm.nih.gov/pubmed/34321058
http://dx.doi.org/10.1186/s13063-021-05449-5
work_keys_str_mv AT henrikgrelz taperingofprescribedopioidsinpatientswithlongtermnonmalignantpaintopioefficacyandeffectsonpainpaincognitionsandqualityoflifeastudyprotocolforarandomizedcontrolledclinicaltrialwitha12monthfollowup
AT patrikmidlov taperingofprescribedopioidsinpatientswithlongtermnonmalignantpaintopioefficacyandeffectsonpainpaincognitionsandqualityoflifeastudyprotocolforarandomizedcontrolledclinicaltrialwitha12monthfollowup
AT andershakansson taperingofprescribedopioidsinpatientswithlongtermnonmalignantpaintopioefficacyandeffectsonpainpaincognitionsandqualityoflifeastudyprotocolforarandomizedcontrolledclinicaltrialwitha12monthfollowup
AT ulfjakobsson taperingofprescribedopioidsinpatientswithlongtermnonmalignantpaintopioefficacyandeffectsonpainpaincognitionsandqualityoflifeastudyprotocolforarandomizedcontrolledclinicaltrialwitha12monthfollowup
AT marcelorivanofischer taperingofprescribedopioidsinpatientswithlongtermnonmalignantpaintopioefficacyandeffectsonpainpaincognitionsandqualityoflifeastudyprotocolforarandomizedcontrolledclinicaltrialwitha12monthfollowup
AT asaringqvist taperingofprescribedopioidsinpatientswithlongtermnonmalignantpaintopioefficacyandeffectsonpainpaincognitionsandqualityoflifeastudyprotocolforarandomizedcontrolledclinicaltrialwitha12monthfollowup